Antibiotics and Innovation Project


Antibiotics and Innovation Project

Project Contact

Linda Paris Manager, Communications, Medical Programs Tel: 202-540-6354

Project Focus:

Antibiotics save untold numbers of human lives every day. Modern medicine depends on their ability to treat and prevent infections such as pneumonia, tuberculosis, and staph. Yet drug-resistant bacteria are spreading in the nation’s communities and too often antibiotics are taken for granted. The U.S. Centers for Disease Control and Prevention estimates that tens of thousands of Americans die each year from infections, and many of those deaths are associated with bacteria that are resistant to treatment by one or more of these drugs. In the past few years, so-called “superbugs” have emerged that cause an even greater public health concern.

The history of antibiotics has repeated itself: drugs are discovered, but bacterial evolution can soon render them ineffective in treating infections. Resistance is fueled by injudicious use of existing drugs and compounded by a failure to develop novel new ones. Many major pharmaceutical companies have limited their investments in this antibiotic innovation, and only two new classes of these substances have reached the market in the past 30 years.

The Pew Charitable Trusts’ Antibiotics and Innovation Project develops and supports policies that will spur innovation of new antibiotics to fight infections today and to ensure a healthy nation in the future.

What is ADAPT?

What is ADAPT? Other Resource

The Antibiotic Development to Advance Patient Treatment bill was introduced to encourage development of antibiotics for patients with serious or life-threatening bacterial infections.

Full Story

New Antibiotics for Limited Populations

New Antibiotics for Limited Populations Issue Brief

The health care community is searching for ways to bring innovative new antibiotics to patients in areas whose treatment options are limited or nonexistent.

Full Story